简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-01-06 09:21 Takeda Announces Favorable Phase 3 Safety and Efficacy Results of TAK-755 as Compared to Standard of Care in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2023-01-05 09:42 Aptorum Group Announces Publication of a Co-authored Paper on its PathsDx Technology - a Rapid-Turnaround Low-Depth Unbiased Metagenomics Sequencing Workflow for Liquid Biopsy based Diagnosis of Infectious Diseases on Illumina Platforms
2023-01-04 15:07 New Prospective Study Evaluates the Accuracy of Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring During Elective Cesarean Section
2023-01-03 10:39 Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
2022-12-30 10:37 Biocytogen Launches RenNano™ Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery
2022-12-23 09:12 Merck Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates
2022-12-21 09:27 Boehringer Ingelheim announces appointments to Board of Managing Directors
2022-12-20 09:40 Boehringer Ingelheim and Click Therapeutics expand their existing Collaboration to develop Prescription Digital Therapeutics for Schizophrenia
2022-12-19 14:30 Biocytogen Announces FDA Clearance of IND Application for Bispecific Antibody YH008
2022-12-19 10:09 Aptorum Group Announces Completion of $3 Million Convertible Note due 2023
2022-12-16 17:55 Dermaliq Therapeutics Announces First Participant Randomized in Phase 1b/2 Trial Evaluating DLQ01 Solution for Treatment of Androgenic Alopecia
2022-12-16 13:11 Mori Memorial Foundation Issues GPCI-2022 & CPS-2022 Report
2022-12-16 09:48 Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
2022-12-16 09:39 CAS Introducing Transformational Capabilities to Accelerate Life Sciences Innovation
2022-12-14 15:34 AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting
2022-12-14 15:25 Cancellation of remaining publicly held registered shares of Vifor Pharma AG
2022-12-14 09:43 European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares
2022-12-13 19:33 Reduced-risk* Potential of Velo as Cigarette Alternative Reinforced by Innovative Real-world Study
2022-12-13 19:30 Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
2022-12-13 19:25 Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases

Business Wire Weibo

Press Releases

Latest Releases